razobazam

{{Short description|Chemical compound}}

{{Drugbox

| verifiedrevid = 443983722

| IUPAC_name = 3,8-dimethyl-4-phenyl-2H-pyrazolo[3,4-b][1,4]diazepine-5,7-dione

| image = Razobazam.svg

| width = 190

| tradename =

| pregnancy_AU =

| pregnancy_US =

| pregnancy_category =

| legal_AU =

| legal_CA =

| legal_UK =

| legal_US =

| legal_status =

| routes_of_administration =

| bioavailability =

| protein_bound =

| metabolism =

| elimination_half-life =

| excretion =

| CAS_number = 78466-98-5

| ATC_prefix =

| ATC_suffix =

| ATC_supplemental =

| PubChem = 71228

| DrugBank_Ref = {{drugbankcite|correct|drugbank}}

| DrugBank =

| UNII_Ref = {{fdacite|correct|FDA}}

| UNII = LZ84VWN0U4

| ChemSpiderID = 64363

| chemical_formula =

| C=14 | H=14 | N=4 | O=2

| smiles = CC1=C2C(=NN1)N(C(=O)CC(=O)N2C3=CC=CC=C3)C

| StdInChI = 1S/C14H14N4O2/c1-9-13-14(16-15-9)17(2)11(19)8-12(20)18(13)10-6-4-3-5-7-10/h3-7H,8H2,1-2H3,(H,15,16)

| StdInChIKey = RHZDHINXKVZTEF-UHFFFAOYSA-N

}}

Razobazam (INN) is a drug which is a benzodiazepine derivative. Its mechanism of action appears to be quite different from that of most benzodiazepine drugs, and it produces nootropic effects in animal studies.{{cite journal | vauthors = Hock FJ, Scheich H | title = Functional activity in the brain of socially deprivated rats produced by an active avoidance test after razobazam (Hoe 175) treatment: a 2-deoxyglucose study | journal = Behavioral and Neural Biology | volume = 46 | issue = 3 | pages = 398–409 | date = November 1986 | pmid = 3814045 | doi = 10.1016/s0163-1047(86)90401-2 }}